ClinicalTrials.gov record
Recruiting Phase 3 Interventional

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

ClinicalTrials.gov ID: NCT05983250

Public ClinicalTrials.gov record NCT05983250. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 20, 2026, 7:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PH-HFpEF)

Study identification

NCT ID
NCT05983250
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Tenax Therapeutics, Inc.
Industry
Enrollment
230 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • TNX-103 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 9, 2024
Primary completion
Sep 30, 2026
Completion
Sep 30, 2028
Last update posted
Feb 17, 2026

2024 – 2028

United States locations

U.S. sites
41
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Tenax Investigational Site Tucson Arizona 85721 Recruiting
Tenax Investigational Site La Jolla California 92037 Recruiting
Tenax Investigational Site Los Angeles California 90033 Recruiting
Tenax Investigational Site Los Angeles California 90048 Recruiting
Tenax Investigational Site Sacramento California 95817 Recruiting
Tenax Investigational Site San Francisco California 94143 Recruiting
Tenax Investigational Site Torrance California 90502 Recruiting
Tenax Investigational Site Jacksonville Florida 32224 Recruiting
Tenax Investigational Site Winter Haven Florida 33881 Recruiting
Tenax Investigational Site Atlanta Georgia 30322 Recruiting
Tenax Investigational Site Chicago Illinois 60208 Recruiting
Tenax Investigational Site Chicago Illinois 60637 Recruiting
Tenax Investigational Site Galesburg Illinois 61401 Recruiting
Tenax Investigational Site Indianapolis Indiana 46202 Recruiting
Tenax Investigational Site Indianapolis Indiana 46260 Recruiting
Tenax Investigational Site Louisville Kentucky 40202 Recruiting
Tenax Investigational Site Boston Massachusetts 02114 Recruiting
Tenax Investigational Site Minneapolis Minnesota 55455 Recruiting
Tenax Investigational Site Rochester Minnesota 55905 Recruiting
Tenax Investigational Site St Louis Missouri 63136 Recruiting
Tenax Investigational Site Omaha Nebraska 68198 Recruiting
Tenax Investigational Site New York New York 10021 Recruiting
Tenax Investigational Site New York New York 10029 Recruiting
Tenax Investigational Site Rochester New York 14621 Recruiting
Tenax Investigational Site Roslyn New York 11576 Recruiting
Tenax Investigational Site Charlotte North Carolina 28203 Recruiting
Tenax Investigational Site Durham North Carolina 27710 Recruiting
Tenax Investigational Site Greensboro North Carolina 27401 Recruiting
Tenax Investigational Site Cincinnati Ohio 45267 Recruiting
Tenax Investigational Site Columbus Ohio 43214 Recruiting
Tenax Investigational Site Pittsburgh Pennsylvania 15212 Recruiting
Tenax Investigational Site Providence Rhode Island 02903 Recruiting
Tenax Investigational Site Charleston South Carolina 29425 Recruiting
Tenax Investigational Site Columbia South Carolina 29044 Recruiting
Tenax Investigational Site Dallas Texas 75204 Recruiting
Tenax Investigational Site Dallas Texas 75390 Recruiting
Tenax Investigational Site Lubbock Texas 79430 Recruiting
Tenax Investigational Site Plano Texas 75093 Recruiting
Tenax Investigational Site Murray Utah 84107 Recruiting
Tenax Investigational Site Richmond Virginia 23298 Recruiting
Tenax Investigational Site Madison Wisconsin 53792 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05983250, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2026 · Synced Apr 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05983250 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →